Tradestie Institutional Equity Comparison Engine
IONS vs KRYS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KRYS Overall Edge
KRYS Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Krystal Biotech, Inc. Common Stock (KRYS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IONS trades at 90.9x Forward P/E with -58.8% operating margin (+54.9% YoY revenue) versus KRYS at 33.1x Forward P/E and 48.4% operating margin (+30.2% YoY). In options structure, IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against KRYS sits in CONSOLIDATION (4th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
KRYS
IONS 90.9x vs KRYS 33.1x Fwd P/E
Growth & Margin Winner
KRYS
Op Margin -58.8% vs 48.4% ยท YoY +54.9% vs +30.2%
Momentum & Technical Winner
KRYS
1Y -59.1% vs +47.9% ยท 52W Pos 2% vs 54%
Options & Structure Winner
KRYS
BREAKDOWN (17th %ile IV) vs CONSOLIDATION (4th %ile IV)
IONS
NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap
$4.7B
1M Return
-33.48%
1Y Return
-59.1%
Forward P/E
90.9x
Unified AI Score
63.9 / 100
BUY
Tech 60.0
Fund 63.0
Flow 73.0
Mom 55.0
KRYS
NASDAQ
Krystal Biotech, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$297.67
-2.48% 1D
Market Cap
$9.1B
1M Return
-5.97%
1Y Return
+47.94%
Forward P/E
33.1x
Unified AI Score
51.1 / 100
HOLD
Tech 59.0
Fund 57.0
Flow 66.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IONS -59.1%
KRYS +47.94%
Spread: +107.04 pp (KRYS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | IONS Revenue | KRYS Revenue | IONS Op. Margin | KRYS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $600M | N/A | -10.2% | N/A | IONS |
| FY2019 | $1.12B | N/A | 32.6% | N/A | IONS |
| FY2020 | $730M | N/A | -23.6% | N/A | IONS |
| FY2021 | $810M | N/A | -3.7% | N/A | IONS |
| FY2022 | $590M | N/A | -69.8% | N/A | IONS |
| FY2023 | $790M | $50M | -44.9% | -216.2% | IONS |
| FY2024 | $710M | $290M | -67.4% | 22.6% | KRYS |
| FY2025 | $940M | $390M | -40.4% | 41.5% | KRYS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IONS | KRYS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.7B | $9.1B | Larger Scale | KRYS |
| Trailing P/E Ratio Valuation | 90.9x | 41.5x | Lower Multiple | KRYS |
| Forward P/E Ratio Valuation | 90.9x | 33.1x | Lower Multiple | KRYS |
| Revenue Growth (YoY) Growth | +54.9% | +30.2% | Higher Growth | IONS |
| Operating Margin (TTM) Profitability | -58.8% | 48.4% | Higher Margin | KRYS |
| Net Profit Margin Profitability | -56.9% | 47.9% | Higher Margin | KRYS |
| Return on Equity (ROE) Capital Efficiency | -108.0% | 17.5% | Higher ROE | KRYS |
| 52-Week Range Position Momentum | 2% ($27โ$87) | 54% ($198โ$383) | Stronger Trend | KRYS |
| Beta / 30D Volatility Risk Regime | 0.18ฮฒ ยท 86% Vol | 0.69ฮฒ ยท 47% Vol | Lower Realized Risk | KRYS |
| Unified Institutional Score Composite Signal | 63.9 / 100 (BUY) | 51.1 / 100 (HOLD) | Higher Composite | IONS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IONS vs KRYS Buy Guide
IONS
BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
KRYS
CONSOLIDATION
98d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IONS nor KRYS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.